Literature DB >> 461277

The search for the ideal influenza vaccine.

F M Davenport.   

Abstract

The history of the development of influenza virus vaccine is traced from its origin with experimental studies of influenza virus in ferrets and mice and the first trials in man. Knowledge of the basis of immunity to the viruses in experimental animals and in man has grown steadily over the years and has been essential to successful immunization. Virus variation affecting the surface antigens of the virus is seen as the principal obstacle to the application of vaccines in man. So significant are the changes occurring during antigenic drift that former concepts of a polyvalent vaccine cannot provide a solution of the problem of the composition of vaccines. Disrupted virus vaccines appear to provide the answer to the prevention of vaccine reactions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 461277      PMCID: PMC2425372          DOI: 10.1136/pgmj.55.640.78

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  36 in total

1.  Influenza: Four Years' Progress.

Authors:  C H Andrewes
Journal:  Br Med J       Date:  1937-09-11

2.  AN EPIDEMIC OF INFLUENZA. RESULTS OF PROPHYLACTIC INOCULATION OF A COMPLEX INFLUENZA A-DISTEMPER VACCINE.

Authors:  J W Brown; M D Eaton; G Meiklejohn; J B Lagen; W J Kerr
Journal:  J Clin Invest       Date:  1941-11       Impact factor: 14.808

3.  RESULTS OF IMMUNIZATION BY MEANS OF ACTIVE VIRUS OF HUMAN INFLUENZA.

Authors:  J Stokes; A D Chenoweth; A D Waltz; R G Gladen; D Shaw
Journal:  J Clin Invest       Date:  1937-03       Impact factor: 14.808

4.  Public Health Weekly Reports for SEPTEMBER 19, 1941.

Authors: 
Journal:  Public Health Rep       Date:  1941-09-19       Impact factor: 2.792

5.  A SIMPLIFIED PROCEDURE FOR THE CONCENTRATION AND PURIFICATION OF INFLUENZA VIRUS.

Authors:  T Francis; J E Salk
Journal:  Science       Date:  1942-11-27       Impact factor: 47.728

6.  An evaluation of influenza immunization: influence of route of administration and vaccine strain.

Authors:  R H Waldman; J O Bond; L P Levitt; E C Hartwig; E C Prather; R L Baratta; J S Neill; P A Small
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

7.  Problems of influenza virus vaccine standardization.

Authors:  N M Tauraso; T C O'Brien; E B Seligman
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

8.  STUDIES ON THE NASAL HISTOLOGY OF EPIDEMIC INFLUENZA VIRUS INFECTION IN THE FERRET : III. HISTOLOGICAL AND SEROLOGICAL OBSERVATIONS ON FERRETS RECEIVING REPEATED INOCULATIONS OF EPIDEMIC INFUENZA VIRUS.

Authors:  T Francis; C H Stuart-Harris
Journal:  J Exp Med       Date:  1938-10-31       Impact factor: 14.307

9.  ANTIBODY RESPONSE OF HUMAN BEINGS FOLLOWING VACCINATION WITH INFLUENZA VIRUSES.

Authors:  G K Hirst; E R Rickard; L Whitman; F L Horsfall
Journal:  J Exp Med       Date:  1942-05-01       Impact factor: 14.307

10.  STUDIES ON IMMUNITY TO SWINE INFLUENZA.

Authors:  R E Shope
Journal:  J Exp Med       Date:  1932-09-30       Impact factor: 14.307

View more
  4 in total

1.  Changing perceptions: of pandemic influenza and public health responses.

Authors:  Adam Kamradt-Scott
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

2.  Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses.

Authors:  M Hamzawi; R Jennings; C W Potter
Journal:  J Hyg (Lond)       Date:  1981-12

Review 3.  History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines.

Authors:  I Barberis; P Myles; S K Ault; N L Bragazzi; M Martini
Journal:  J Prev Med Hyg       Date:  2016-09

Review 4.  Cardiovascular implications of COVID-19 versus influenza infection: a review.

Authors:  Muhammad Shahzeb Khan; Izza Shahid; Stefan D Anker; Scott D Solomon; Orly Vardeny; Erin D Michos; Gregg C Fonarow; Javed Butler
Journal:  BMC Med       Date:  2020-12-18       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.